Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of CCR5 Inhibition as a Complement to Lung Transplant Induction Immunosuppression

NCT06853223 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06853223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06853223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of CCR5 Inhibition as a Complement to Lung Transplant Induction Immunosuppression
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Recruiting
Start date
December 7, 2025
Completion date
August 14, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung injury(ali), lung transplantation, natural killer cell mediated immunity, primary graft dysfunction